Abstract
Objective
To determine the dose-response curve of inhaled nitric oxide (NO) in terms of pulmonary vasodilation and improvement in PaO2 in adults with severe acute respiratory failure.
Design
Prospective randomized study.
Setting
A 14-bed ICU in a teaching hospital.
Patients
6 critically ill patients with severe acute respiratory failure (lung injury severity score ≥2.5) and pulmonary hypertension.
Interventions
8 concentrations of inhaled NO were administered at random: 100, 400, 700, 1000, 1300, 1600, 1900 and 5000 parts per billion (ppb). Control measurements were performed before NO inhalation and after the last concentration administered. After an NO exposure of 15–20 min, hemodynamic parameters obtained from a fiberoptic Swan-Ganz catheter, blood gases, methemoglobin blood concentrations and intratracheal NO and nitrogen dioxide (NO2) concentrations, continuously monitored using a bedside chemiluminescence apparatus, were recorded on a Gould ES 1000 recorder. In 2 patients end-tidal CO2 was also recorded.
Results
The administration of 100–2000 ppb of inhaled NO induced: i) a dose-dependent decrease in pulmonary artery pressure and in pulmonary vascular resistance (maximum decrease −25%); ii) a dose-dependent increase in PaO2 via a dose-dependent reduction in pulmonary shunt; iii) a slight but significant decrease in PaCO2 via a reduction in alveolar dead space; iv) a dose-dependent increase in mixed venous oxygen saturation (SVO2). Systemic hemodynamic variables and methemoglobin blood concentrations did not change. Maximum NO2 concentrations never exceeded 165 ppb. In 2 patients, 91% and 74% of the pulmonary vasodilation was obtained for inhaled NO concentrations of 100 ppb.
Conclusion
In hypoxemic patients with pulmonary hypertension and severe acute respiratory failure, therapeutic inhaled NO concentrations are in the range 100–2000 ppb. The risk of toxicity related to NO inhalation is therefore markedly reduced. Continuous SVO2 monitoring appears useful at the bedside for determining optimum therapeutic inhaled NO concentrations in a given patient.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338:1173–1174
Rich GF, Murphy GD, Roos CM, Johns RA (1993) Inhaled nitric oxide. Selective pulmonary vasodiation in cardiac surgical patients. Anesthesiology 78:1028–1035
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement in oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19:443–449
Zapol WM (1993) Minidose inhaled nitric oxide: less is better. Intensive Care Med 19:433–434
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038–2047
Fratacci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator of Heparine-Protamine vasoconstriction in sheep. Anesthesiology 75:990–999
Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78:427–435
Gerlach H, Rossaint R, Pappert D Falke KJ (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499–502
Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138:720–723
Gonzales C, Lejean L, Royer C, Dreux S., Rouby JJ, Viars P (1990) Monitorrage continu et simultané de la PaO2 et de la pression artérielle sanglante (1990) Ann Fr Anesth Reanim 9 (Suppl) R2
Rouby JJ, Puybasset L, Mourgeon E, Segal E, Poète P, Viars P (1993) Respiratory effects of increasing concentrations of inhaled nitric oxide in patients with ARDS. Anesthesiology 79:A226 (abstract)
Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WD (1993) Inhaled nitric oxide in congenital heart disease. Circulation 87:447–453
Roberts JD, Polaner DM, Lang P, Zapol WD (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn., Lancet 340:818–819
Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819–820
Girard C, Lehot JJ, Pannetier JC, Filley S, Pfrench P, Estanove S (1992) Inhaled nitric oxide after mitral valve replacement in patient with chronic pulmonary artery hypertension. Anesthesiology 77:880–883
Adnot S, Kouyoumdjian C, Deffouilloy C, Andrivet P, Sediame S, Herigault R, Fratacci MD (1993) Hemodynamic and gas exchange response to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 148:310–316
Roberts JD, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, Zapol W (1993) Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 72:246–254
Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE (1993) Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 147:1080–1086
Chenoweth DE, Steven W, Cooper BA, Tony EH, Stewart RW, Blackstone EH, Kirlin JW (1981) Complement activation during cardiopulmonary bypass. N Engl J Med 304:497
Ylikorkala O, Saarela E, Viinikka L (1981) Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass. J Thorac Cardiovasc Surg 49:32–34
Colman RW (1990) Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 49:32–34
Jahr J, Grände PO (1992) Pulmonary and hemodynamic effects of extracorporeal circulation in the cat and the beneficial effect of prostacyclin. Intensive Care Med 18:118–122
Rasmussen TR, Kjaergaard SK, Tarp U, Pedersen OF (1992) Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 146:654–659
Bauer MA, Utell MJ, Morrow PE, Spees DM, Gibb FR (1986) 0.30 ppm nitrogen dioxyde inhalation potentiated exercise induced bronchospasm in asthmatics. Am Rev Respir Dis 135:1203–1208
Ben-Jebria A, Marthan R, Savineau JP (1992) Effect of in vitro nitrogen dioxide exposure on human bronchial smooth muscle response. Am Rev Respir Dis 146:378–382
Foubert L, Fleming B, Latimer R, Jonas M, Oduro A, Borland C, Higenbottam T (1992) Safety guidelines for use of nitric oxide. Lancet 339:1615–1616
Högman M, Frostell C, Arnberg H, hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341:1664–1665
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puybasset, L., Rouby, J.J., Mourgeon, E. et al. Inhaled nitric oxide in acute respiratory failure: Dose-response curves. Intensive Care Med 20, 319–327 (1994). https://doi.org/10.1007/BF01720903
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720903